The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.
暂无分享，去创建一个
Masato Nakamura | K. Muro | S. Morita | H. Baba | Masahiko Watanabe | K. Sugihara | T. Satoh | Y. Shimada | Y. Sakata | Y. Sasaki | Yasuhide Yamada | Y. Komatsu | Keiichi Takahashi | H. Mishima | M. Watanabe | Y. Yamada